el-Ad B, Bornstein N M, Fuchs P, Korczyn A D
Department of Neurology, Elias Sourasky Medical Center, Tel-Aviv University, Israel.
Neurology. 1996 Sep;47(3):657-9. doi: 10.1212/wnl.47.3.657.
We assessed the therapeutic efficacy and outcome of mechanical ventilation (MV) in patients with acute respiratory failure (ARF) following ischemic stroke (IS) or intracerebral hemorrhage (ICH), retrospectively graded by patients with IS (n = 881) and ICH (n = 108) admitted to our service during 11 years, according to the severity of their clinical state and to whether we employed MV. Outcome was recorded in terms of survival and duration of MV and compared with patients with neuromuscular (NM) diseases. We found a very high in-hospital mortality in stroke patients who were treated with ventilation (90.5% for IS and 87.5% for ICH) compared with NM patients (29%). We conclude that MV in stroke patients with ARF is not life-saving, and its use should be considered only after considering other potentially important factors.
我们评估了缺血性卒中(IS)或脑出血(ICH)后急性呼吸衰竭(ARF)患者机械通气(MV)的治疗效果和结局,对在11年期间入住我院的881例IS患者和108例ICH患者,根据其临床状态的严重程度以及是否使用MV进行回顾性分级。结局根据生存率和MV持续时间进行记录,并与神经肌肉(NM)疾病患者进行比较。我们发现,与NM疾病患者(29%)相比,接受通气治疗的卒中患者院内死亡率非常高(IS患者为90.5%,ICH患者为87.5%)。我们得出结论,ARF的卒中患者使用MV不能挽救生命,仅在考虑其他潜在重要因素后才应考虑使用。